As pharmaceutical companies face a tsunami of lawsuits and criminal probes stemming from the opioid epidemic, they are accused of using the coronavirus crisis to rehabilitate their image.
As pharmaceutical companies face a tsunami of lawsuits and criminal probes stemming from the opioid epidemic, they are accused of using the coronavirus crisis to rehabilitate their image.